Clinical Trial

A Study of ORN252 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and tolerability of ORN252 in healthy adult participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-23; most recent amendment 2026-04-13.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT07439796
Lead Sponsor Orna Therapeutics, Inc.
Conditions Healthy Volunteers - Male and Female
Enrollment 20 participants
Start Date 2026-03-16
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-16